We have previously confirmed apparent pro-survival reaction to fingolimod in the hippocampus of 12-month-old AD model mice that involved sphingosine kinase, ceramide kinase, and BCL2 [27]. This evidence concerns the gene BCL2 and Alzheimer disease.